DE3876724T2 - Die zur freisetzung bioaktiver substanzen kontrollierende umhuellungszubereitung. - Google Patents

Die zur freisetzung bioaktiver substanzen kontrollierende umhuellungszubereitung.

Info

Publication number
DE3876724T2
DE3876724T2 DE8888113933T DE3876724T DE3876724T2 DE 3876724 T2 DE3876724 T2 DE 3876724T2 DE 8888113933 T DE8888113933 T DE 8888113933T DE 3876724 T DE3876724 T DE 3876724T DE 3876724 T2 DE3876724 T2 DE 3876724T2
Authority
DE
Germany
Prior art keywords
release
bioactive substances
coating preparation
preparation controlling
controlling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888113933T
Other languages
English (en)
Other versions
DE3876724D1 (de
Inventor
Anil S Ambegoankar
Roger Alan Howells
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AAIPharma Inc
Original Assignee
Air Products and Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Air Products and Chemicals Inc filed Critical Air Products and Chemicals Inc
Publication of DE3876724D1 publication Critical patent/DE3876724D1/de
Application granted granted Critical
Publication of DE3876724T2 publication Critical patent/DE3876724T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
DE8888113933T 1987-09-03 1988-08-26 Die zur freisetzung bioaktiver substanzen kontrollierende umhuellungszubereitung. Expired - Fee Related DE3876724T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/092,743 US4891223A (en) 1987-09-03 1987-09-03 Controlled release delivery coating formulation for bioactive substances

Publications (2)

Publication Number Publication Date
DE3876724D1 DE3876724D1 (de) 1993-01-28
DE3876724T2 true DE3876724T2 (de) 1993-05-27

Family

ID=22234898

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888113933T Expired - Fee Related DE3876724T2 (de) 1987-09-03 1988-08-26 Die zur freisetzung bioaktiver substanzen kontrollierende umhuellungszubereitung.

Country Status (10)

Country Link
US (1) US4891223A (de)
EP (1) EP0305918B1 (de)
JP (1) JPH0825870B2 (de)
KR (1) KR910002075B1 (de)
CA (1) CA1330942C (de)
DE (1) DE3876724T2 (de)
DK (1) DK175383B1 (de)
ES (1) ES2052656T3 (de)
NO (1) NO178486C (de)
ZA (1) ZA886551B (de)

Families Citing this family (108)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59000232D1 (de) * 1989-02-11 1992-09-10 Bayer Ag Arzneimittel mit kontrollierter wirkstoffabgabe.
US5091185A (en) * 1990-06-20 1992-02-25 Monsanto Company Coated veterinary implants
US5707637A (en) * 1990-12-14 1998-01-13 American Cyanamid Company Granulated soil insecticidal-nematicidal compositions with reduced mammalian dermal toxicity
US5378475A (en) * 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
IT1245889B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari.
US6764697B1 (en) 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
US5652196A (en) * 1991-07-22 1997-07-29 Oms Investments, Inc. Timed release of water-soluble plant nutrients
US5335449A (en) * 1991-08-15 1994-08-09 Net/Tech International, Inc. Delivery system for an agriculturally active chemical
US5526607A (en) * 1991-08-15 1996-06-18 Net/Tech International Water dispersible delivery system for an agriculturally active chemical
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
IT1260505B (it) * 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
FR2692754B1 (fr) * 1992-06-26 1995-06-30 Ube Industries Compositions chimiques pour l'agriculture, en granules a double enrobage.
EP0621032B1 (de) * 1993-04-23 2000-08-09 Novartis AG Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
DE69330123T2 (de) * 1993-06-07 2001-10-11 Oms Investments Inc Langzeitabgabe von wasserlöslichen Pflanzennährstoffen
JP3720386B2 (ja) * 1993-12-27 2005-11-24 住友製薬株式会社 薬物放出制御製剤
US5395626A (en) * 1994-03-23 1995-03-07 Ortho Pharmaceutical Corporation Multilayered controlled release pharmaceutical dosage form
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
US5698002A (en) * 1994-11-21 1997-12-16 Lesco Inc. Controlled release fertilizers utilizing an epoxy polymer primer coat and methods of production
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
US6039975A (en) * 1995-10-17 2000-03-21 Hoffman-La Roche Inc. Colon targeted delivery system
US6245351B1 (en) 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
US20060067999A1 (en) * 1996-03-25 2006-03-30 Wyeth Extended release formulation
KR100337048B1 (ko) * 1997-01-20 2002-05-16 고또오 슈운기찌 시한방출제어형 피복농약입제
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
US6511477B2 (en) * 1997-03-13 2003-01-28 Biocardia, Inc. Method of drug delivery to interstitial regions of the myocardium
KR100522248B1 (ko) * 1997-05-29 2006-02-01 동아제약주식회사 이중제어방출막구조의경구서방성제제및그제조방법
US5902598A (en) * 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
DE69814122T2 (de) * 1997-10-09 2004-03-18 Dexcel Pharma Technologies Ltd. Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt
US6607751B1 (en) * 1997-10-10 2003-08-19 Intellipharamaceutics Corp. Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
EP1035834B1 (de) * 1997-12-05 2002-04-17 Alza Corporation Osmotische darreichungsform mit zwei mantelschichten
GR1003326B (el) * 1998-01-15 2000-03-03 Μεθοδος παραγωγης συστηματων εγκλωβισμου βιολογικα ελεγχομενης αποδοσης
DE19820529A1 (de) 1998-05-08 1999-11-11 Lohmann Therapie Syst Lts Wirkstoff enthaltende orale und mucosale Zubereitung mit steuerbarer Wirkstofffreisetzung und ihre Verwendung
US6531152B1 (en) 1998-09-30 2003-03-11 Dexcel Pharma Technologies Ltd. Immediate release gastrointestinal drug delivery system
US20040121014A1 (en) * 1999-03-22 2004-06-24 Control Delivery Systems, Inc. Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6217895B1 (en) 1999-03-22 2001-04-17 Control Delivery Systems Method for treating and/or preventing retinal diseases with sustained release corticosteroids
US6632451B2 (en) 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
CN101288663A (zh) * 1999-09-14 2008-10-22 史密丝克莱恩比彻姆公司 制备水性包被小球粒的方法
WO2001052815A1 (en) * 2000-01-20 2001-07-26 Delsys Pharmaceutical Corporation Multi-step drug dosage forms
WO2001056544A2 (en) * 2000-02-04 2001-08-09 Depomed, Inc. Shell-and-core dosage form approaching zero-order drug release
US6761895B2 (en) * 2000-04-17 2004-07-13 Yamanouchi Pharmaceutical Co., Ltd. Drug delivery system for averting pharmacokinetic drug interaction and method thereof
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US6444316B1 (en) 2000-05-05 2002-09-03 Halliburton Energy Services, Inc. Encapsulated chemicals for use in controlled time release applications and methods
US20030157247A1 (en) * 2000-06-14 2003-08-21 Yoshiro Chikami Method for producing coated bioactive granule
AU2001291243A1 (en) 2000-09-27 2002-04-08 Verion Inc. Instant water dissolvable encapsulate and process
MXPA03006217A (es) * 2001-01-12 2004-10-15 Sun Pharmaceutical Ind Ltd Sistema de administracion espaciada de farmacos.
HUP0501071A3 (en) 2001-03-13 2007-06-28 Penwest Pharmaceutical Co Chronotherapeutic dosage forms
KR200249057Y1 (ko) * 2001-03-22 2001-10-19 김진환 뚜껑, 받침대에 합체된 하수역류. 악취방지 장치
EP1377276B1 (de) * 2001-04-10 2011-10-05 Sun Pharma Advanced Research Company Limited Zubereitung zur getakteten freisetzung
US6635675B2 (en) 2001-11-05 2003-10-21 Cypress Bioscience, Inc. Method of treating chronic fatigue syndrome
MXPA04006163A (es) * 2001-12-20 2004-11-01 Pharmacia Corp Formas de dosis de liberacion sostenida del orden-cero y metodo de fabricacion de las mismas.
EP1482910A1 (de) * 2002-03-05 2004-12-08 Ranbaxy Laboratories, Ltd. Orale pharmazeutische zusammensetzung mit modifizierter freisetzung
US8871241B2 (en) * 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) * 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7785627B2 (en) * 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US7220433B2 (en) * 2003-06-27 2007-05-22 Ethicon, Inc. Compositions for parenteral administration and sustained-release of therapeutic agents
US8389008B2 (en) 2003-09-19 2013-03-05 Penwest Pharmaceuticals Co. Delayed release dosage forms
US8163114B2 (en) * 2004-04-07 2012-04-24 New Jersey Institute Of Technology Netshape manufacturing processes and compositions
US20060024361A1 (en) * 2004-07-28 2006-02-02 Isa Odidi Disintegrant assisted controlled release technology
US10624858B2 (en) * 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
JP2008525313A (ja) * 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20060204613A1 (en) * 2005-02-18 2006-09-14 Castro Armando J Chewing gum containing flavor delivery systems
US20060286200A1 (en) * 2005-04-18 2006-12-21 Castro Armando J Confections containing flavor delivery systems
US7905287B2 (en) 2005-04-19 2011-03-15 Halliburton Energy Services Inc. Methods of using a polymeric precipitate to reduce the loss of fluid to a subterranean formation
US7943555B2 (en) * 2005-04-19 2011-05-17 Halliburton Energy Services Inc. Wellbore treatment kits for forming a polymeric precipitate to reduce the loss of fluid to a subterranean formation
CA2789262C (en) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Pharma-informatics system
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
JP2006327943A (ja) * 2005-05-23 2006-12-07 Towa Yakuhin Kk 経時的溶出遅延を抑制したテイストマスク錠剤
US7833945B2 (en) * 2005-07-15 2010-11-16 Halliburton Energy Services Inc. Treatment fluids with improved shale inhibition and methods of use in subterranean operations
US8455404B2 (en) * 2005-07-15 2013-06-04 Halliburton Energy Services, Inc. Treatment fluids with improved shale inhibition and methods of use in subterranean operations
US20070072775A1 (en) 2005-09-29 2007-03-29 Oms Investments, Inc. Granular controlled release agrochemical compositions and process for the preparation thereof
US8440695B2 (en) * 2005-11-09 2013-05-14 St Jude Children's Research Hospital Use of chloroquine to treat metabolic syndrome
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US8124598B2 (en) * 2006-09-14 2012-02-28 Sharon Sageman 7-keto DHEA for psychiatric use
WO2008122965A2 (en) 2007-04-04 2008-10-16 Sigmoid Pharma Limited Pharmaceutical cyclosporin compositions
US20100160274A1 (en) * 2007-09-07 2010-06-24 Sharon Sageman 7-KETO DHEA for Psychiatric Use
AU2009279372A1 (en) 2008-08-06 2010-02-11 Gosforth Centre (Holdings) Pty Ltd Compositions and methods for treating psychiatric disorders
JP2012515765A (ja) * 2009-01-22 2012-07-12 アボット ヘルスケア プライベート リミテッド 時間治療用医薬組成物
NZ619375A (en) * 2009-04-28 2015-03-27 Proteus Digital Health Inc Highly reliable ingestible event markers and methods for using the same
TW201041607A (en) * 2009-05-01 2010-12-01 Eurand Inc Orally disintegrating tablet compositions comprising combinations of non-opioid and opioid analgesics
GB2483815B (en) 2009-05-18 2013-12-25 Sigmoid Pharma Ltd Composition comprising oil drops
CA2785468A1 (en) * 2009-12-23 2011-06-30 Psivida Us, Inc. Sustained release delivery devices
RU2012143791A (ru) 2010-04-07 2014-05-20 Проутьюс Диджитал Хэлс, Инк. Миниатюрное проглатываемое устройство
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
WO2014120669A1 (en) 2013-01-29 2014-08-07 Proteus Digital Health, Inc. Highly-swellable polymeric films and compositions comprising the same
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
JP6435279B2 (ja) * 2013-03-15 2018-12-05 アダマ・マクテシム・リミテッド 土壌中の肥料及び他の農業用化学物質の効率的な吸収のための人工環境
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
GB201319792D0 (en) * 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US20150133516A1 (en) 2013-11-13 2015-05-14 Brian K. Adams Methods and Compositions for Treating ADHD
HUE053624T2 (hu) 2014-11-07 2021-07-28 Sublimity Therapeutics Ltd Ciklosporint tartalmazó készítmények
CA3029602A1 (en) 2015-07-02 2017-01-05 University Of Louisville Research Foundation, Inc. Edible plant-derived microvesicle compositions for delivery of mirna and methods for treatment of cancer
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
BR112019000861B1 (pt) 2016-07-22 2020-10-27 Proteus Digital Health, Inc dispositivo eletrônico
TWI735689B (zh) 2016-10-26 2021-08-11 日商大塚製藥股份有限公司 製造含有可攝食性事件標記之膠囊之方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4177056A (en) * 1974-06-27 1979-12-04 Ciba-Geigy Corporation Water-insoluble hydrophilic copolymers used as carriers for medicaments and pesticides
US4111201A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4423099A (en) * 1980-07-28 1983-12-27 Ciba-Geigy Corporation Membrane modified hydrogels
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
DE3278491D1 (en) * 1981-07-15 1988-06-23 Key Pharma Sustained release theophyline
US4716041A (en) * 1984-02-10 1987-12-29 A/S Alfred Benzon Diffusion coated multiple-units dosage form
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
GB8518301D0 (en) * 1985-07-19 1985-08-29 Fujisawa Pharmaceutical Co Hydrodynamically explosive systems

Also Published As

Publication number Publication date
NO883918L (no) 1989-03-06
US4891223A (en) 1990-01-02
DK175383B1 (da) 2004-09-20
NO178486C (no) 1996-04-10
DE3876724D1 (de) 1993-01-28
DK490788D0 (da) 1988-09-02
NO883918D0 (no) 1988-09-02
KR910002075B1 (ko) 1991-04-03
NO178486B (no) 1996-01-02
JPH0269414A (ja) 1990-03-08
KR890004688A (ko) 1989-05-09
JPH0825870B2 (ja) 1996-03-13
EP0305918A1 (de) 1989-03-08
DK490788A (da) 1989-03-04
CA1330942C (en) 1994-07-26
ZA886551B (en) 1990-05-30
ES2052656T3 (es) 1994-07-16
EP0305918B1 (de) 1992-12-16

Similar Documents

Publication Publication Date Title
DE3876724T2 (de) Die zur freisetzung bioaktiver substanzen kontrollierende umhuellungszubereitung.
DE69210124T2 (de) Geschmackabdeckende Beschichtung zur Herstellung kaubarer Arzneitabletten
DE3886965T2 (de) Zubereitungen zur gesteuerten Wirkstofffreisetzung.
DE69022557T2 (de) Verfahren zur Herstellung von Copolyestercarbonaten.
ES2021699B3 (es) Proceso para la preparacion de esteres.
DE59003447D1 (de) Verfahren zur Herstellung von Benztriazolen.
DE3883608D1 (de) Verfahren zur Herstellung von Maltosepulver.
DE69007323T2 (de) Verfahren zur Herstellung von sec.-Butylbenzol.
DE69220113D1 (de) Verfahren zur Herstellung von menschlichem Serum Albumin
DE3884164D1 (de) Wässriges Trennmittel zur Herstellung von Polyurethan-Formkörpern.
DE58906418D1 (de) Verfahren zur Herstellung von Festkörpern.
DE58901037D1 (de) Vorrichtung zur herstellung von klareisstuecken.
IT8805224A0 (it) Composizione a base di poliesteri per la liberazione controllata di sostanze medicamentose.
DE58908736D1 (de) Verfahren zur Herstellung von Cyclopropylamin.
DE69014576T2 (de) Verfahren zur Herstellung von 3-Dibutylamino-6-methyl-7-anilinofluoran.
DE69332766D1 (de) Verfahren zur Herstellung von Sulfonaten
DE69230358T2 (de) Substituiertes N-Fluoropyridiniumsulfonat, Zwischenprodukte und Verfahren zur Herstellung davon
DE69206307T2 (de) Verfahren zur Herstellung von N-Methylolacrylamid.
DE68919887T2 (de) Verfahren zur Herstellung von 1-alpha,25-dihydroxy-vitamin D2 und dessen 24-Epimer.
DE59200677D1 (de) Verfahren zur Herstellung von Alkansulfonylbenzoesäuren.
DE59203023D1 (de) Verfahren zur Herstellung von Hydroxydiphenylen.
DE9321186U1 (de) Vorrichtung zur Herstellung von Schokoladenartikeln
NO885446L (no) Fremgangsmaate for fremstilling av kinolincarboxylsyrer.
DE59204105D1 (de) Verfahren zur Herstellung von Difluorbenzaldehyden.
DE69219720D1 (de) Verfahren zur Herstellung von Streptovaricin C

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: APPLIED ANALYTICAL INDUSTRIES, INC., WILMINGTON, N

8327 Change in the person/name/address of the patent owner

Owner name: AAIPHARMA INC.(N.D.GES.D.STAATES DELAWARE), WILMIN

8339 Ceased/non-payment of the annual fee